GLP-1s, Urolithin A & Urolithin B: Uncovering the Mitochondria-Metabolism-Brain Axis

GLP-1s, Urolithin A & Urolithin B: Uncovering the Mitochondria-Metabolism-Brain Axis

Could metabolic aging, chronic anxiety, and depression all share the same biological root?

In this episode of The Energy Code, Dr. Mike Belkowski reviews three newly published studies that, when viewed together, point toward an emerging concept he calls the mitochondria-metabolism-brain axis.

The first paper explores how GLP-1 medications may influence mitochondrial biology beyond weight loss by interacting with pathways involved in mitochondrial biogenesis, oxidative stress, and cellular resilience. The second investigates how Urolithin A restored mitophagy and eliminated anxiety-like behavior in animal models. The third demonstrates how Urolithin B improved depression-like behavior by activating mitochondrial quality-control pathways through SLP2 and the PINK1/Parkin signaling system.

While much of the evidence remains preclinical, the convergence across these independent research groups is striking.

Rather than focusing on three different diseases, the episode explores one shared biological thread: mitochondrial quality control.

If these findings continue to translate into humans, they could fundamentally reshape how we think about metabolism, aging, inflammation, resilience, and brain health.

(Educational content only, not medical advice.)

-

Articles Discussed in Episode:

The GLP-1–Mitochondria Axis in Metabolic Aging

Urolithin A Abolishes High Anxiety and Rescues the Associated Mitochondria-Related Transcriptomic Signatures and Synaptic Function

Urolithin B Ameliorates Depressive-Like Behavior and Hippocampal Neuronal Damage in Depressed Rats via Regulation of the SLP2/PINK1/Parkin Signaling Pathway

-

Key Quotes From Dr. Mike:

"The real question isn't whether one of these compounds works — it's whether we're uncovering a broader mitochondria-metabolism-brain axis."

"Mitochondrial dysfunction sits at the center of metabolic aging."

"GLP-1 drugs may be touching the exact mitochondrial machinery that declines with age."

"Urolithin A didn't simply reduce anxiety — it appeared to restore the mitochondrial quality control system underlying it."

"Urolithin B improved behavior, protected hippocampal neurons, and reduced neuroinflammation."

"Mitochondrial quality control may be one of the shared nodes connecting metabolism, aging, inflammation, and the brain."

"The mitochondrion is beginning to look less like a power plant and more like a resilience hub."

-

Key Points

⚡ Three newly published studies explored metabolic aging, anxiety, and depression—but all converged on mitochondrial biology as a shared mechanism.

⚡ The episode introduces the emerging concept of the mitochondria-metabolism-brain axis.

⚡ A new Aging Cell review proposes that mitochondrial dysfunction sits at the center of metabolic aging.

⚡ Age-related declines in NAD, sirtuins, PGC-1α, mitochondrial biogenesis, and mitophagy may collectively drive metabolic decline.

⚡ GLP-1 receptor agonists may influence mitochondrial function through AMPK, PGC-1α, NRF2, and mitophagy pathways.

⚡ Despite compelling mechanisms, direct mitochondrial benefits of GLP-1 drugs in humans remain an active hypothesis—not established fact.

⚡ Large clinical trials continue to demonstrate significant cardiovascular and metabolic benefits from GLP-1 therapies.

⚡ Neurons have extraordinarily high energy demands, making the brain especially vulnerable to mitochondrial dysfunction.

⚡ A new Biological Psychiatry study found that Urolithin A eliminated anxiety-like behavior in multiple rodent models.

⚡ Urolithin A restored mitochondrial quality control by improving mitophagy through the PINK1/Parkin pathway.

⚡ The anti-anxiety effects occurred without sedation and primarily benefited animals exhibiting high anxiety.

⚡ Urolithin A also restored neuronal connectivity, dendritic complexity, synaptic function, and Mitofusin-2 expression.

⚡ A second study found that Urolithin B significantly improved depression-like behavior in stressed rats.

⚡ Urolithin B reduced neuroinflammation, preserved hippocampal neurons, increased BDNF and serotonin, and lowered corticosterone.

⚡ Researchers identified SLP2 as a key upstream regulator driving PINK1/Parkin-mediated mitophagy.

⚡ Knocking down SLP2 largely eliminated Urolithin B's protective effects, strengthening the proposed mechanism.

⚡ All three papers independently converged on mitochondrial quality control and mitophagy as central biological processes.

⚡ The PINK1/Parkin pathway appeared repeatedly across metabolic aging, anxiety, and depression research.

⚡ Mitochondrial quality control may represent a shared biological node linking seemingly unrelated chronic diseases.

⚡ The most important takeaway isn't any single molecule—it's the growing evidence that mitochondrial resilience may influence multiple organ systems simultaneously.

-

Episode timeline

00:00 – One Question Connects Three Diseases

  • Could metabolic aging, anxiety, and depression all share one biological mechanism?

02:30 – The GLP-1 Mitochondrial Axis

  • Aging Cell review

  • Mitochondrial dysfunction and metabolic aging

  • NAD, sirtuins, PGC-1α, mitophagy

  • Human vs. animal evidence

16:40 – Why the Brain Depends on Healthy Mitochondria

  • Neuronal energy demands

  • Why mitochondrial dysfunction disproportionately affects the brain

18:40 – Urolithin A and Anxiety

  • Biological Psychiatry study

  • Anxiety models

  • Mitophagy restoration

  • PINK1/Parkin pathway

  • Mitofusin-2

27:00 – Urolithin B and Depression

  • Brain Research Bulletin study

  • SLP2 signaling

  • PINK1/Parkin activation

  • Hippocampal neuroprotection

  • Behavioral improvements

36:30 – The Bigger Picture

  • How all three studies converge

  • The mitochondria-metabolism-brain axis

  • Why mitochondrial quality control may become one of the defining concepts in longevity science

41:30 – Final Takeaways

    • What we know

    • What remains speculative

    • Why this emerging field deserves close attention

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs:

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(381)

Mitochondrial Medicine Is Accelerating: 8 New Breakthroughs You Need to Know

Mitochondrial Medicine Is Accelerating: 8 New Breakthroughs You Need to Know

Light just won the Nobel Prize — and at virtually the same time, mitochondrial science is exploding with new discoveries. In this solo episode of The Energy Code, Dr. Mike Belkowski breaks down some o...

8 Okt 55min

Beyond Mitochondria: The Invisible Energy System Running Your Body | Harry Massey

Beyond Mitochondria: The Invisible Energy System Running Your Body | Harry Massey

What if human health is governed by more than chemistry alone? In this episode of The Energy Code, Dr. Mike Belkowski sits down with Harry Massey, pioneer in bioenergetics and founder of NES Health an...

1 Okt 1h 12min

The Missing Link That Could Make Every Peptide Work Better

The Missing Link That Could Make Every Peptide Work Better

Why do some people experience incredible results from peptides while others barely notice a difference? In this episode of The Energy Code, Dr. Mike Belkowski and Don Bailey explore one of the most ov...

24 Sep 1h 25min

The Biggest Peptide Breakthroughs of 2026: MOTS-c, Retatrutide, FDA Shifts & What Happens Next

The Biggest Peptide Breakthroughs of 2026: MOTS-c, Retatrutide, FDA Shifts & What Happens Next

The peptide landscape is evolving faster than ever before — and 2026 may prove to be the biggest turning point yet. In this episode, Dr. Mike Belkowski breaks down the most important developments shap...

17 Sep 34min

The Light System Explained: Can Light, Frequency & Energy Transform Your Health? | Jarrod Barakett

The Light System Explained: Can Light, Frequency & Energy Transform Your Health? | Jarrod Barakett

In this special episode of The Energy Code, Dr. Mike Belkowski sits down with Jarrod Barakett, President of The Light System, to explore the intersection of light frequencies, bioenergetics, cellular ...

10 Sep 1h 13min

10 Breakthrough Mitochondrial Studies That Could Change Medicine Forever

10 Breakthrough Mitochondrial Studies That Could Change Medicine Forever

In this special Research Jamboree episode of The Energy Code, Dr. Mike Belkowski takes listeners on a rapid-fire tour through some of the most exciting mitochondrial research published over the past f...

3 Sep 36min

The Ultimate Guide to Intranasal Peptides: Brain Repair, Focus, Sleep, Longevity & More

The Ultimate Guide to Intranasal Peptides: Brain Repair, Focus, Sleep, Longevity & More

Intranasal peptides have become one of the most exciting frontiers in peptide research — but which ones actually make sense, and why? In this episode, Dr. Mike Belkowski breaks down the science behind...

27 Aug 1h 3min

Populært innen Helse

fastlegen
rss-gukild-johaug
psykodrama
hvordan-har-du-det-mann
leger-om-livet
rss-kunsten-a-leve
rss-skravla-gar
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-dagen-for-dagen
foreldreradet
treningsprat
morten-ramm-lar-kakla-ga-til-du-sovner
hjernesterk
rss-lopedrommen
rss-loping-for-nybegynnere
g-punktet
fryktlos
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
helsetipspodden
kjed-deg-i-sovn-verdens-kjedeligste-podcast